Skip to Content

2.5/1000 4222 (Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg)

Generic Name: metformin/saxagliptin

Pill with imprint 2.5/1000 4222 is Yellow, Capsule-shape and has been identified as Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.

Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 2.5/1000 4222

Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222 Front
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222 Back
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222

Kombiglyze XR

Generic Name
metformin/saxagliptin
Imprint
2.5/1000 4222
Strength
metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg
Color
Yellow
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
carboxymethylcellulose sodium, hypromellose 2208 (15000 mPa.s), magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00003-4222
00310-6125 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.